Related Article
In the midsummer of 2026, Ruipu Medical welcomed yet another strategic-level international certification milestone—successfully obtaining the Medical Device Marketing Authorization (MDMA) issued by the Saudi Food and Drug Authority (SFDA). This marks that Ruipu's inhaled nitric oxide system and supporting disposable accessories have officially been approved to enter the Saudi market, taking a solid step forward in the global high-end respiratory therapy equipment field.
Congratulations! Sister company Ruipu Medical has been granted the authoritative Saudi SFDA certification, adding another major milestone to its internationalization strategy.
